Levoprotiline

This classification denotes an antidepressant agent with the molecular formula C20H23NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier KYX86D468O, chemically known as 1-(9,10-ethanoanthracen-9(10h)-yl)-3-(methylamino)propan-2-ol but generally known as levoprotiline, which bears US NIH Compound Identifier 53511. European Medicines Agency schedules Levoprotiline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08488MIG. The term LEVOPROTILINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 1, No. 4, 1987, List 27). LEVOPROTILINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule levoprotiline under HS 29221980 and SITC 51461. As of Q4 2014, LEVOPROTILINE remains the US FDA Preferred Term for this commodity. Levoprotiline bears US NLM identifiers UMLS ID C0125662 and NCI Concept Code C83884. SMILES: OC(CC12CCC(c3c2cccc3)c2c1cccc2)CNC.